Active Shortage Injection Anesthesia

Bupivacaine Hydrochloride In · 3,125 days since initial FDA posting

Brand: BUPIVACAINE HYDROCHLORIDE

FDA lists Bupivacaine Hydrochloride In as Active Shortage (Kindos Pharmaceuticals Co. Ltd.).

Availability on file: Available

Bupivacaine Hydrochloride Injection: Active Shortage

Available Contact your pharmacist if you are affected.

Shortage Details

Generic Name
Bupivacaine Hydrochloride Injection
Manufacturer
Kindos Pharmaceuticals Co. Ltd.
Dosage Form
Injection
Presentation
Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52)
Package NDC
71288-723-52

Status & Timeline

Status
Active Shortage
Availability
Available
First Reported
Feb 20, 2018
Last Updated
Aug 19, 2025
Therapeutic Category
Anesthesia

Row fields from the FDA Drug Shortages database via openFDA.

Shortage Reason

Meitheal Pharmaceuticals is distributor/labeler; product is available

Nearby, Other Bupivacaine Shortage Records

Bupivacaine Hydrochloride Injection

Somerset Therapeutics, LLC

Injection

Active Shortage

Bupivacaine Hydrochloride Injection

Somerset Therapeutics, LLC

Injection

Active Shortage

Bupivacaine Hydrochloride Injection

Kindos Pharmaceuticals Co. Ltd.

Injection

Active Shortage

Bupivacaine Hydrochloride Injection

Kindos Pharmaceuticals Co. Ltd.

Injection

Active Shortage

Bupivacaine Hydrochloride Injection

Kindos Pharmaceuticals Co. Ltd.

Injection

Active Shortage

Bupivacaine Hydrochloride Injection

Kindos Pharmaceuticals Co. Ltd.

Injection

Active Shortage

FDA reason on file: Meitheal Pharmaceuticals is distributor/labeler; product is available. General shortage guidance lives on the tracker hub.

← All Drug Shortages